Enbrel Promotions May Use AUC Data, Erosion Scores, Not Superiority Claims
Executive Summary
Immunex' Enbrel promotions may use data on percentages of patients with no increase in erosion scores and area under the curve data, but may not use the data to make superiority claims to methotrexate, the approval letter for a new indication for Enbrel states.